| 发明名称 |
Stable Protein Formulations |
| 摘要 |
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
|
| 申请公布号 |
US2010166774(A1) |
申请公布日期 |
2010.07.01 |
| 申请号 |
US20060086876 |
申请日期 |
2006.12.19 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
DALI MANISHA M.;DAHLHEIM CHARLES E.;BORSADIA SUNITA;NARINGREKAR VIJAY H.;GANDHI RAJESH BABULAL;NERURKAR MANOJ |
| 分类号 |
A61K39/395;A61P37/00;A61P37/06 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
